Akane Ishihara

3.5k total citations
68 papers, 2.6k citations indexed

About

Akane Ishihara is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems and Molecular Biology. According to data from OpenAlex, Akane Ishihara has authored 68 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cellular and Molecular Neuroscience, 36 papers in Endocrine and Autonomic Systems and 32 papers in Molecular Biology. Recurrent topics in Akane Ishihara's work include Regulation of Appetite and Obesity (35 papers), Neuropeptides and Animal Physiology (32 papers) and Receptor Mechanisms and Signaling (27 papers). Akane Ishihara is often cited by papers focused on Regulation of Appetite and Obesity (35 papers), Neuropeptides and Animal Physiology (32 papers) and Receptor Mechanisms and Signaling (27 papers). Akane Ishihara collaborates with scholars based in Japan, United States and Taiwan. Akane Ishihara's co-authors include Akio Kanatani, Hisashi Iwaasa, Satoshi Mashiko, Akira Gomori, Takehiro Fukami, Takeshi Tanaka, Hiroshi Saitō, Shigeru Tokita, Hiroko Matsushita and Kazuhiko Takahashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Akane Ishihara

67 papers receiving 2.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Akane Ishihara 1.1k 885 797 563 444 68 2.6k
Emmanuel Canet 803 0.7× 717 0.8× 379 0.5× 596 1.1× 81 0.2× 44 2.0k
Hisayuki Ohata 709 0.6× 1.1k 1.2× 317 0.4× 838 1.5× 169 0.4× 111 2.8k
Joyce Hwa 621 0.6× 450 0.5× 347 0.4× 645 1.1× 264 0.6× 41 1.7k
Mark H. Perrone 576 0.5× 1.2k 1.3× 713 0.9× 600 1.1× 106 0.2× 81 3.3k
Ahmad Fawzi 810 0.7× 910 1.0× 493 0.6× 686 1.2× 411 0.9× 53 2.2k
Blanka Železná 618 0.6× 800 0.9× 493 0.6× 636 1.1× 263 0.6× 111 2.0k
Claudio Pietra 357 0.3× 1.2k 1.3× 791 1.0× 703 1.2× 192 0.4× 79 2.8k
Oksana Palyha 1.8k 1.6× 509 0.6× 413 0.5× 981 1.7× 226 0.5× 23 2.5k
Ravi P. Nargund 1.9k 1.7× 744 0.8× 339 0.4× 949 1.7× 177 0.4× 72 3.1k
Cristina Blázquez 241 0.2× 1.6k 1.8× 1.5k 1.9× 787 1.4× 630 1.4× 39 5.2k

Countries citing papers authored by Akane Ishihara

Since Specialization
Citations

This map shows the geographic impact of Akane Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akane Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akane Ishihara more than expected).

Fields of papers citing papers by Akane Ishihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akane Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akane Ishihara. The network helps show where Akane Ishihara may publish in the future.

Co-authorship network of co-authors of Akane Ishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Akane Ishihara. A scholar is included among the top collaborators of Akane Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akane Ishihara. Akane Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumoto, Tomoyuki, Minoru Tanaka, Ryosuke Nakanishi, et al.. (2019). Transcutaneous carbon dioxide attenuates impaired oxidative capacity in skeletal muscle in hyperglycemia model. General Physiology and Biophysics. 38(3). 237–244. 3 indexed citations
2.
Haga, Yuji, Sayaka Mizutani, Akira Naya, et al.. (2010). Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists. Bioorganic & Medicinal Chemistry. 19(2). 883–893. 8 indexed citations
3.
Suzuki, Takao, Minoru Moriya, Toshihiro Sakamoto, et al.. (2009). Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(11). 3072–3077. 17 indexed citations
4.
Moriya, Ryuichi, Satoshi Mashiko, Akane Ishihara, et al.. (2009). Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice. Peptides. 30(7). 1318–1322. 15 indexed citations
5.
Sakamoto, Toshihiro, Minoru Moriya, Toshiyuki Takahashi, et al.. (2009). Novel orally active NPY Y5 receptor antagonists: Synthesis and structure–activity relationship of spiroindoline class compounds. Bioorganic & Medicinal Chemistry. 17(14). 5015–5026. 10 indexed citations
6.
Ito, Masahiko, Akane Ishihara, Akira Gomori, et al.. (2009). Mechanism of the anti‐obesity effects induced by a novel Melanin‐concentrating hormone 1‐receptor antagonist in mice. British Journal of Pharmacology. 159(2). 374–383. 30 indexed citations
7.
Moriya, Minoru, Shunji Sakuraba, Toshihiro Sakamoto, et al.. (2009). Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists. Bioorganic & Medicinal Chemistry Letters. 19(16). 4589–4593. 14 indexed citations
8.
Suzuki, Takao, Minoru Kameda, Makoto Ando, et al.. (2009). Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(18). 5339–5345. 15 indexed citations
9.
Takahashi, Toshiyuki, Yuji Haga, Toshihiro Sakamoto, et al.. (2009). Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(13). 3511–3516. 13 indexed citations
10.
Ando, Makoto, Nagaaki Sato, Tsuyoshi Nagase, et al.. (2009). Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor. Bioorganic & Medicinal Chemistry. 17(16). 6106–6122. 16 indexed citations
11.
Ogino, Yoshio, Norikazu Ohtake, Kenji Matsuda, et al.. (2008). Syntheses and structure–activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1′-cyclohexan]-4′-yl]benzimidazole NPY Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(18). 4997–5001. 19 indexed citations
12.
Ito, Makoto, Jun Suzuki, Minoru Sasaki, et al.. (2007). Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high‐fat diet. Hepatology Research. 37(1). 50–57. 185 indexed citations
13.
Ito, Makoto, Jun Suzuki, Motoko Sasaki, et al.. (2006). Development of nonalcoholic steatohepatitis model through combination of high-fat diet and tetracycline with morbid obesity in mice. Hepatology Research. 34(2). 92–98. 25 indexed citations
14.
Mashiko, Satoshi, Akane Ishihara, Hisashi Iwaasa, et al.. (2006). A Pair-Feeding Study Reveals That a Y5 Antagonist Causes Weight Loss in Diet-Induced Obese Mice by Modulating Food Intake and Energy Expenditure. Molecular Pharmacology. 71(2). 602–608. 37 indexed citations
15.
Ito, Sayaka, Ryo Yoshimoto, Yasuhisa Miyamoto, et al.. (2005). Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor. European Journal of Pharmacology. 529(1-3). 40–46. 15 indexed citations
16.
Mashiko, Satoshi, Akane Ishihara, Hisashi Iwaasa, et al.. (2003). Characterization of Neuropeptide Y (NPY) Y5 Receptor-Mediated Obesity in Mice: Chronic Intracerebroventricular Infusion ofd-Trp34NPY. Endocrinology. 144(5). 1793–1801. 51 indexed citations
17.
Ishihara, Akane, Akio Kanatani, Megumu Okada, et al.. (2002). Blockade of body weight gain and plasma corticosterone levels in Zucker fatty rats using an orally active neuropeptide Y Y1 antagonist. British Journal of Pharmacology. 136(3). 341–346. 25 indexed citations
18.
Ishihara, Akane, et al.. (1998). Influence of Hypobaric-Hypoxia on Fiber Type Distribution of the Rat Extensor Digitorum Longus Muscle. 46(1). 1–6. 2 indexed citations
19.
Kanatani, Akio, Junko Itô, Akane Ishihara, et al.. (1998). NPY-induced feeding involves the action of a Y1-like receptor in rodents. Regulatory Peptides. 75-76. 409–415. 51 indexed citations
20.
Kanatani, Akio, Akane Ishihara, Shuichi Asahi, et al.. (1996). Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake.. Endocrinology. 137(8). 3177–3182. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Canet Breakdown of academic impact, for papers by Hisayuki Ohata Breakdown of academic impact, for papers by Joyce Hwa Breakdown of academic impact, for papers by Mark H. Perrone Breakdown of academic impact, for papers by Ahmad Fawzi Breakdown of academic impact, for papers by Blanka Železná Breakdown of academic impact, for papers by Claudio Pietra Breakdown of academic impact, for papers by Oksana Palyha Breakdown of academic impact, for papers by Ravi P. Nargund Breakdown of academic impact, for papers by Cristina Blázquez
Rankless by CCL
2026